Your search for Warfarin returned 9 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Miscellaneous remove
Older than 2 years remove
Home remove

Your search for Warfarin returned 9 results

Sort Results:

Relevant Recent
Drug News

Fruits Most Likely to Cause Warfarin Interactions

Purpose: The aim of this review is to discuss possible interactions that may occur between warfarin and fruit products. Methods: A literature search was conducted using the search terms: “warfarin (Coumadin®) and fruit interactions, warfarin and fruit, warfarin and fruit juice, case reports and clinical trials”.
Drug News

Warfarin-Associated ICH in Stroke Patients: High or Low Risk?

Background and Purpose- The aim was to investigate the risk of intracerebral hemorrhage (ICH) in patients with ischemic stroke taking warfarin and whether this risk changed over time. The patients was studied in two 4-year periods (inclusion 2001-2004: follow-up until 2005 and inclusion 2005–2008: follow-up until 2009) for which rates of subsequent ICH were calculated.
Drug News

Warfarin vs. Rivaroxaban for Nonvalvular AF

Background: Nonvalvular atrial fibrillation (AF) is common in elderly patients, who face an elevated risk of stroke but difficulty sustaining warfarin treatment. Methods and Results-There were 6229 patients (44%) aged 75 years with AF and 2 stroke risk factors randomized to warfarin (target international normalized ratio 2.0-3.0) or rivaroxaban (20mg daily; 15mg if creatinine clearance…
Drug News

Genetic Variants Linked to Bleeding Risk in Warfarin Patients

The influence of warfarin pharmacogenomics on major bleeding risk has been little studied in long-term users and non–specialist care settings. We conducted a case–control study to evaluate associations between CYP2C9*2/*3, VKORC1(1173), and CYP4F2*3 variants and major bleeding among patients treated with warfarin in a community setting.
Drug News

Warfarin vs. Rivaroxaban: Outcomes of Temporary Interruption

Background- During long-term anticoagulation in atrial fibrillation, temporary interruptions (TIs) of therapy are common, but the relationship between patient outcomes and TIs has not been well studied. Methods and Results- In the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition …
Drug News

A-Fib + Stroke Patients Not Getting Proper Medications Post-Discharge

Despite current guidelines, many patients with atrial fibrillation (A-fib) and ischemic stroke (IS) are not receiving antithrombotic therapy after hospital discharge or are receiving antiplatelet therapy alone, increasing their risk of major vascular events.